阿斯利康前高管在华被控非法交易
Chinese prosecutors have charged two of AstraZeneca’s former senior employees with illegal trade, unlawful collection of personal information, and medical insurance fraud, the company said this week.
AstraZeneca disclosed the charges in its fourth-quarter earnings ...
⚠️ 风险分析 中
摘要：阿斯利康前高管在华被控非法交易、非法收集个人信息及医保欺诈。
影响：事件凸显在华外企面临严格的数据合规与商业行为监管压力，可能影响其市场声誉与运营。
建议：在华外企应加强内部合规审查，确保数据收集与商业活动符合中国法律法规。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.